Level A· Stronger Clinical EvidenceSystematic ReviewPubMed

Clinical Outcomes of Adipose-Derived Cell-Based Therapies Versus Platelet-Rich Plasma in Knee Osteoarthritis: A Systematic Review.

Piyapanyamongkhon P., Rojpalakorn W., Yudtanahiran N., Itthipanichpong T., Limskul D., Thamrongskulsiri N.

Systematic Review on Knee Osteoarthritis, Osteoarthritis, published in Indian J Orthop (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Indian J Orthop (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
42558512
DOI
10.1007/s43465-026-01689-2

Abstract (original English)

Background Knee osteoarthritis (OA) is a common degenerative joint condition for which current treatments primarily provide symptom control without restoring cartilage. Biologic injectables such as platelet-rich plasma (PRP) and adipose-derived cellular preparations have gained interest as potential disease-modifying options. This review compares the current clinical evidence regarding their relative effectiveness. Methods Following PRISMA 2020 guidelines, PubMed, Scopus, Cochrane Library, Europe PMC, and CNKI were searched. Eligible studies were level 1-2 clinical trials directly comparing PRP with adipose-derived cell-based therapies in knee OA. Pain, function, quality of life, sports activity, and complications were assessed. Quality was evaluated using MINORS. Results Three studies (two hundred forty-one knees) were included, all high quality (MINORS 19-24). Both PRP and adipose-derived cell-based therapies significantly improved pain, function, and quality of life with no reported complications. Two studies showed no difference between PRP and microfragmented or autologous adipose tissue (MFAT/AAT) at 6-12 months. One study found culture-expanded adipose-derived stem cells (ADSCs) provided greater improvements in pain (WOMAC, VAS), stiffness, and several SF-36 domains compared with PRP at 6 months. Conclusion PRP and adipose-derived cell-based therapies are safe and effect

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research